Therapy cap remains at $3,000 for physical therapy and speech-language pathology, with a separate $3,000 cap for occupational therapy
Applicability Across Genders and Conditions PT-141 is effective for: Men with erectile dysfunction, especially non-responders to PDE5 inhibitors Women diagnosed with hypoactive sexual desire disorder (HSDD) Individuals with underlying health issues like diabetes, hypertension, or neurological conditions Complementary Use with Other Therapies PT-141 is often used in combination with other treatments, such as PDE5 inhibitors or compounded therapies like Erexafil, to optimize sexual function from both vascular and neural pathways
How to prepare for an eligibility discussion Because qualification is ultimately a clinical judgment, the most useful thing you can do is arrive prepared
Citations Rosenstock J, Wysham C, Fras JP, et al